Meloni, A., Pistoia, L., Positano, V., De Luca, A., Martini, N., Spasiano, A., et al
Mounjaro was tested over 72 weeks with the following results: Those taking 5mg lost 16% of their starting weight Those taking 10mg lost 21.4% of their starting weight Those taking 15mg lost 22.5% of their starting weight Wegovy was tested over 68 weeks with people losing 15% or more of their starting weight at the maintenance dose of 2.4mg
It's unlikely that your GLP-1 drugs personal injury lawsuit will go to trial
Note: Tirzepatide is the only one of these medications that is both a GLP-1 and GIP agonist
It is also explored for its ability to accelerate recovery following physical stress or injury, making it relevant in performance-focused studies
Who Should Avoid GLP-1s